ISSN: 1352-4585

Journal Home

Journal Guideline

Multiple Sclerosis Q1 Unclaimed

SAGE Publications Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Multiple Sclerosis is a journal indexed in SJR in Neurology (clinical) and Neurology with an H index of 152. It has an SJR impact factor of 1,901 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,901.

Multiple Sclerosis focuses its scope in these topics and keywords: multiple, patients, sclerosis, ms, progressive, remyelination, relapsing, syndrome, isolated, clinical, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Neurology (Q1) Neurology (clinical) (Q1) Neurology (clinical) (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,901

SJR Impact factor

152

H Index

236

Total Docs (Last Year)

862

Total Docs (3 years)

6283

Total Refs

3735

Total Cites (3 years)

713

Citable Docs (3 years)

3.68

Cites/Doc (2 years)

26.62

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

The Lancet Neurology Q1
Neuro-Oncology Q1
Nature Reviews Neurology Q1
JAMA Neurology Q1
Molecular Neurodegeneration Q1

Compare this journals

Aims and Scope

Best articles by citations

Prognostic factors in multidisciplinary rehabilitation treatment in multiple sclerosis: an outcome study

Two-year results from a phase 2 extension study of oral amiselimod in relapsing multiple sclerosis

Modulation of autoimmune responses by intravenous immunoglobulin (IVIg)

Prevalence of salivary human herpesviruses in pediatric multiple sclerosis cases and controls

Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRB1*1501, CCR5 deletion mutation, apolipoprotein E)

Identification and validation of clinically meaningful benchmarks in the 12-item Multiple Sclerosis Walking Scale

Expression of chemokine receptors in the different clinical forms of multiple sclerosis

Motor determinants of gait in 100 ambulatory patients with multiple sclerosis

Cytokines in multiple sclerosis: pro-inflammation or pro-remyelination?

Failure to Detect Measles Virus Rna, by Reverse Transcription-Polymerase Chain Reaction, in Peripheral Blood Leucocytes of Patients with Multiple Sclerosis

Continuing optic nerve atrophy following optic neuritis: a serial MRI study

Protective personality traits: High openness and low neuroticism linked to better memory in multiple sclerosis

SHOW MORE ARTICLES

Are we in need of NEDA?

Discontinuation of disease-modifying therapy in patients with multiple sclerosis over age 60

Multiple sclerosis in childhood: clinical features of 149 cases

Multiple sclerosis patients with and without sexual dysfunction: are there any differences?

A "kissing lesion": In-vivo 7T evidence of meningeal inflammation in early multiple sclerosis

Multiple sclerosis relapse phenotype is an important, neglected, determinant of disease outcome -NO

Viruses in chronic progressive neurologic disease

A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients

Forceps minor damage and co-occurrence of depression and fatigue in multiple sclerosis

Caffeine and alcohol intakes have no association with risk of multiple sclerosis

Autoreactivity to myelin antigens related to HLA associations with multiple sclerosis

Survival of multiple sclerosis in Finland between 1964 and 1993